0001367644-20-000139.txt : 20200819 0001367644-20-000139.hdr.sgml : 20200819 20200819170800 ACCESSION NUMBER: 0001367644-20-000139 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200818 FILED AS OF DATE: 20200819 DATE AS OF CHANGE: 20200819 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bailey Sue CENTRAL INDEX KEY: 0001403769 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 201117740 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DRIVE STREET 2: SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 wf-form4_159787126712250.xml FORM 4 X0306 4 2020-08-18 0 0001367644 Emergent BioSolutions Inc. EBS 0001403769 Bailey Sue 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 1 0 0 0 Common Stock 2020-08-18 4 S 0 4665 128.3095 D 32595 D Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices between $128.25 and $128.47. /s/ S. Scott Lieberman, Attorney-in-fact 2020-08-19